Nitric Oxide and Cardiovascular Dysfunction in Sepsis
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
6
Page:
165-173
Author(s):
Jamil Assreuy
Coagulation and Sepsis
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
6
Page:
175-182
Author(s):
F. R. Machado and E. Silva
Bacterial Recognition and Induced Cell Activation in Sepsis
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
6
Page:
183-191
Author(s):
Paulo S. Martins, Milena K. Colo Brunialti, Maria d. L. Fernandes, Leandro S. W. Martos, Natalia E. Gomes, Otelo Rigato and Reinaldo Salomao
Pathogenesis-Oriented Targets for Adjunctive Therapy
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
6
Page:
193-200
Author(s):
Otelo Rigato, Eliezer Silva and Reinaldo Salomao
Mechanisms of Action of Hypertonic Saline Resuscitation in Severe Sepsis and Septic Shock
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
6
Page:
201-206
Author(s):
L. F. Poli-de-Figueiredo, R. J. Cruz Jr., P. Sannomiya and M. Rocha-e-Silva
Epidemiology of Severe Sepsis Around the World
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
6
Page:
207-212
Author(s):
Derek C. Angus, Carlos A. Pires Pereira and Eliezer Silva
The Lung in Sepsis: Guilty or Innocent?
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
6
Page:
213-216
Author(s):
E. L.V. Costa, I. A.L. Schettino and G. P.P. Schettino
Surviving Sepsis Campaign: A Project to Change Sepsis Trajectory
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
6
Page:
217-222
Author(s):
Eliezer Silva, Nelson Akamine, Reinaldo Salomao, Sean R. Townsend, Richard P. Dellinger and Mitchell Levy
Targets and Tools: Recent Advances in the Development of Anti-HCV Nucleic Acids
Journal:
Infectious Disorders - Drug Targets
Volume:
6
Page:
121-145
Author(s):
C. Romero-Lopez, F. J. Sanchez-Luque and A. Berzal-Herranz
Editorial [Hot Topic:The Extranuclear Life of the Nuclear Receptor Hormone Family: New Therapeutic Possibilities (Guest Editor: Sandra Incerpi)]
Journal:
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Volume:
6
Page:
233-234
Author(s):
Sandra Incerpi